OA
AGN

Oxbow Advisors’s Allergan plc AGN Stock Holding History

Oxbow Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-13,826
Closed -$2.91M – 287
2016
Q4 		$2.91M Sell
13,826
-712
-5% -$147K 0.36% 75
2016
Q3 		$3.35M Sell
14,538
-262
-2% -$64K 0.46% 66
2016
Q2 		$3.41M Buy
+14,800
New +$3.41M 0.49% 62
2016
Q1 		– Sell
-23,751
Closed -$7.43M – 273
2015
Q4 		$7.43M Buy
23,751
+12,289
+107% +$3.66M 0.93% 30
2015
Q3 		$3.12M Buy
11,462
+20
+0.2% +$6.14K 0.51% 63
2015
Q2 		$3.47M Sell
11,442
-550
-5% -$164K 0.45% 64
2015
Q1 		$3.57M Buy
+11,992
New +$3.42M 0.53% 53

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Oxbow Advisors's AGN Position: Q1 2017 in Review

Oxbow Advisors sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 13,826 shares — an estimated $2.91M sold.

Oxbow Advisors first reported a position in AGN in Q1 2015 and held it in 7 quarters. The position peaked at $7.43M in Q4 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Oxbow Advisors reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Oxbow Advisors sold 13,826 Allergan plc shares in Q1 2017, an estimated $2.91M.
  • Oxbow Advisors first reported a position in Allergan plc in Q1 2015 and held it in 7 quarters.
  • Oxbow Advisors's Allergan plc position peaked at $7.43M in Q4 2015.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Oxbow Advisors's 13F filing for Q1 2017, filed 28 Apr 2017.